Replies to post #210488 on Biotech Values

[mcbio]

GT Retreatment:

I think this is the company (4d Molecular) in #4 that I must have been thinking over. Here is a link to a talk where they mention it briefly around the 4:15 mark

Interesting, thanks. Sounds like the speaker said the tech allows them to expose vector pool to human IVIG to develop vectors which evade pre-existing immunity in the population. I wonder how close to the clinic they are with this tech. Would be interesting to see them go public some day.

BTW, I did end up taking a position in SELB.